Physiological characterization and molecular identification of some rare yeast species causing onychomycosis

Onychomycosis are infections with a variety of etiological agents. Although dermatophytes are responsible for most infections, yeasts are gaining importance as agents of these pathologies. The use of antifungals has increased the incidence of what had been considered rare or novel pathogens. We reid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal de mycologie médicale 2021-06, Vol.31 (2), p.101121-101121, Article 101121
Hauptverfasser: Montoya, Alexandra M., Luna-Rodríguez, Carolina E., Bonifaz, Alexandro, Treviño-Rangel, Rogelio de J., Rojas, Olga C., González, Gloria M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 101121
container_issue 2
container_start_page 101121
container_title Journal de mycologie médicale
container_volume 31
creator Montoya, Alexandra M.
Luna-Rodríguez, Carolina E.
Bonifaz, Alexandro
Treviño-Rangel, Rogelio de J.
Rojas, Olga C.
González, Gloria M.
description Onychomycosis are infections with a variety of etiological agents. Although dermatophytes are responsible for most infections, yeasts are gaining importance as agents of these pathologies. The use of antifungals has increased the incidence of what had been considered rare or novel pathogens. We reidentify three rare yeasts from a culture collection of onychomycosis agents by matrix-assisted laser desorption/ionization time of flight/mass spectrometry (MALDI-TOF/MS) and sequencing the internal transcribed spacer (ITS) regions or the intergenic spacer (IGS) 1 region of ribosomal DNA (rDNA), and present their enzymatic and antifungal susceptibility profiles. We performed a phenotypical characterization and molecular identification of five yeast isolates. We tested the urease, gelatinase, DNase, phospholipase, protease, and esterase activities, as well as the hemolytic activity. We evaluated the antifungal susceptibility to amphotericin B, fluconazole, anidulafungin and caspofungin. Phenotypic methods could not identify the isolates. MALDI-TOF/MS was able to properly identify Candida duobushameulonii. The five isolates were successfully identified by sequence analysis as Candida duobushaemulonii, Meyerozyma caribbica and Cutaneotrichosporon dermatis. Candida duobushameulonii showed hemolytic, phospholipase, and protease activities. Meyerozyma caribbica was positive for gelatinase and protease activities. All antifungals exhibited minimum inhibitory concentrations (MICs) ≤2μg/mL against both species. The three isolates of Cutaneotrichosporon dermatis showed urease, DNase, and esterase activities, and resistance to echinocandins (MICs ≥8μg/mL), while amphotericin B and fluconazole exhibited low MICs against these isolates (0.50–2μg/mL). Sequencing of the ITS or IGS1 regions of rDNA remains the best method for identifying cryptic species over other commercially available systems. More reports are needed to define the enzymatic and antifungal profiles for these species. This is the first report of Meyerozyma caribbica and Cutaneotrichosporon dermatis as etiological agents of onychomycosis.
doi_str_mv 10.1016/j.mycmed.2021.101121
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2493454410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1156523321000111</els_id><sourcerecordid>2493454410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-87c37d19bc049e83fb80875bbd46d9d7c8252a9a33ccd310717aea6a74781eab3</originalsourceid><addsrcrecordid>eNp9kE1v1DAQQC1URD_gH6DKRy7Z2rETJxckVAGtVAkOcLYm40nXqyTe2glS-PV4SXvtaayZN56Zx9hHKXZSyPrmsBtXHMntSlHKU0qW8g27kMaoQmjdnuW3rOqiKpU6Z5cpHYSo6qrS79i5UnVZa6kv2PBzvyYfhvDoEQaOe4iAM0X_F2YfJg6T42MYCJcBIveOptn3Gf1fDD1PYSQeIRJfCdLM05HQU-IIS_LTIw_TivuQNw3Jp_fsbQ9Dog_P8Yr9_vb11-1d8fDj-_3tl4cC815z0RhUxsm2Q6FbalTfNaIxVdc5XbvWGWzKqoQWlEJ0SgojDRDUYLRpJEGnrtin7d9jDE8LpdmOPiENA0wUlmRL3SpdaS1FRvWGYgwpRertMfoR4mqlsCfP9mA3z_bk2W6ec9v184SlO9Veml7EZuDzBlC-84-naFP2MiE5Hwln64J_fcI_Rr-S8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2493454410</pqid></control><display><type>article</type><title>Physiological characterization and molecular identification of some rare yeast species causing onychomycosis</title><source>Elsevier ScienceDirect Journals</source><creator>Montoya, Alexandra M. ; Luna-Rodríguez, Carolina E. ; Bonifaz, Alexandro ; Treviño-Rangel, Rogelio de J. ; Rojas, Olga C. ; González, Gloria M.</creator><creatorcontrib>Montoya, Alexandra M. ; Luna-Rodríguez, Carolina E. ; Bonifaz, Alexandro ; Treviño-Rangel, Rogelio de J. ; Rojas, Olga C. ; González, Gloria M.</creatorcontrib><description>Onychomycosis are infections with a variety of etiological agents. Although dermatophytes are responsible for most infections, yeasts are gaining importance as agents of these pathologies. The use of antifungals has increased the incidence of what had been considered rare or novel pathogens. We reidentify three rare yeasts from a culture collection of onychomycosis agents by matrix-assisted laser desorption/ionization time of flight/mass spectrometry (MALDI-TOF/MS) and sequencing the internal transcribed spacer (ITS) regions or the intergenic spacer (IGS) 1 region of ribosomal DNA (rDNA), and present their enzymatic and antifungal susceptibility profiles. We performed a phenotypical characterization and molecular identification of five yeast isolates. We tested the urease, gelatinase, DNase, phospholipase, protease, and esterase activities, as well as the hemolytic activity. We evaluated the antifungal susceptibility to amphotericin B, fluconazole, anidulafungin and caspofungin. Phenotypic methods could not identify the isolates. MALDI-TOF/MS was able to properly identify Candida duobushameulonii. The five isolates were successfully identified by sequence analysis as Candida duobushaemulonii, Meyerozyma caribbica and Cutaneotrichosporon dermatis. Candida duobushameulonii showed hemolytic, phospholipase, and protease activities. Meyerozyma caribbica was positive for gelatinase and protease activities. All antifungals exhibited minimum inhibitory concentrations (MICs) ≤2μg/mL against both species. The three isolates of Cutaneotrichosporon dermatis showed urease, DNase, and esterase activities, and resistance to echinocandins (MICs ≥8μg/mL), while amphotericin B and fluconazole exhibited low MICs against these isolates (0.50–2μg/mL). Sequencing of the ITS or IGS1 regions of rDNA remains the best method for identifying cryptic species over other commercially available systems. More reports are needed to define the enzymatic and antifungal profiles for these species. This is the first report of Meyerozyma caribbica and Cutaneotrichosporon dermatis as etiological agents of onychomycosis.</description><identifier>ISSN: 1156-5233</identifier><identifier>EISSN: 1773-0449</identifier><identifier>DOI: 10.1016/j.mycmed.2021.101121</identifier><identifier>PMID: 33626414</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Candida duobushaemulonii ; Cutaneotrichosporon dermatis ; Enzyme activity ; Meyerozyma caribbica ; Onychomycosis ; Susceptibility</subject><ispartof>Journal de mycologie médicale, 2021-06, Vol.31 (2), p.101121-101121, Article 101121</ispartof><rights>2021 Elsevier Masson SAS</rights><rights>Copyright © 2021 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-87c37d19bc049e83fb80875bbd46d9d7c8252a9a33ccd310717aea6a74781eab3</citedby><cites>FETCH-LOGICAL-c362t-87c37d19bc049e83fb80875bbd46d9d7c8252a9a33ccd310717aea6a74781eab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1156523321000111$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33626414$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montoya, Alexandra M.</creatorcontrib><creatorcontrib>Luna-Rodríguez, Carolina E.</creatorcontrib><creatorcontrib>Bonifaz, Alexandro</creatorcontrib><creatorcontrib>Treviño-Rangel, Rogelio de J.</creatorcontrib><creatorcontrib>Rojas, Olga C.</creatorcontrib><creatorcontrib>González, Gloria M.</creatorcontrib><title>Physiological characterization and molecular identification of some rare yeast species causing onychomycosis</title><title>Journal de mycologie médicale</title><addtitle>J Mycol Med</addtitle><description>Onychomycosis are infections with a variety of etiological agents. Although dermatophytes are responsible for most infections, yeasts are gaining importance as agents of these pathologies. The use of antifungals has increased the incidence of what had been considered rare or novel pathogens. We reidentify three rare yeasts from a culture collection of onychomycosis agents by matrix-assisted laser desorption/ionization time of flight/mass spectrometry (MALDI-TOF/MS) and sequencing the internal transcribed spacer (ITS) regions or the intergenic spacer (IGS) 1 region of ribosomal DNA (rDNA), and present their enzymatic and antifungal susceptibility profiles. We performed a phenotypical characterization and molecular identification of five yeast isolates. We tested the urease, gelatinase, DNase, phospholipase, protease, and esterase activities, as well as the hemolytic activity. We evaluated the antifungal susceptibility to amphotericin B, fluconazole, anidulafungin and caspofungin. Phenotypic methods could not identify the isolates. MALDI-TOF/MS was able to properly identify Candida duobushameulonii. The five isolates were successfully identified by sequence analysis as Candida duobushaemulonii, Meyerozyma caribbica and Cutaneotrichosporon dermatis. Candida duobushameulonii showed hemolytic, phospholipase, and protease activities. Meyerozyma caribbica was positive for gelatinase and protease activities. All antifungals exhibited minimum inhibitory concentrations (MICs) ≤2μg/mL against both species. The three isolates of Cutaneotrichosporon dermatis showed urease, DNase, and esterase activities, and resistance to echinocandins (MICs ≥8μg/mL), while amphotericin B and fluconazole exhibited low MICs against these isolates (0.50–2μg/mL). Sequencing of the ITS or IGS1 regions of rDNA remains the best method for identifying cryptic species over other commercially available systems. More reports are needed to define the enzymatic and antifungal profiles for these species. This is the first report of Meyerozyma caribbica and Cutaneotrichosporon dermatis as etiological agents of onychomycosis.</description><subject>Candida duobushaemulonii</subject><subject>Cutaneotrichosporon dermatis</subject><subject>Enzyme activity</subject><subject>Meyerozyma caribbica</subject><subject>Onychomycosis</subject><subject>Susceptibility</subject><issn>1156-5233</issn><issn>1773-0449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kE1v1DAQQC1URD_gH6DKRy7Z2rETJxckVAGtVAkOcLYm40nXqyTe2glS-PV4SXvtaayZN56Zx9hHKXZSyPrmsBtXHMntSlHKU0qW8g27kMaoQmjdnuW3rOqiKpU6Z5cpHYSo6qrS79i5UnVZa6kv2PBzvyYfhvDoEQaOe4iAM0X_F2YfJg6T42MYCJcBIveOptn3Gf1fDD1PYSQeIRJfCdLM05HQU-IIS_LTIw_TivuQNw3Jp_fsbQ9Dog_P8Yr9_vb11-1d8fDj-_3tl4cC815z0RhUxsm2Q6FbalTfNaIxVdc5XbvWGWzKqoQWlEJ0SgojDRDUYLRpJEGnrtin7d9jDE8LpdmOPiENA0wUlmRL3SpdaS1FRvWGYgwpRertMfoR4mqlsCfP9mA3z_bk2W6ec9v184SlO9Veml7EZuDzBlC-84-naFP2MiE5Hwln64J_fcI_Rr-S8w</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Montoya, Alexandra M.</creator><creator>Luna-Rodríguez, Carolina E.</creator><creator>Bonifaz, Alexandro</creator><creator>Treviño-Rangel, Rogelio de J.</creator><creator>Rojas, Olga C.</creator><creator>González, Gloria M.</creator><general>Elsevier Masson SAS</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210601</creationdate><title>Physiological characterization and molecular identification of some rare yeast species causing onychomycosis</title><author>Montoya, Alexandra M. ; Luna-Rodríguez, Carolina E. ; Bonifaz, Alexandro ; Treviño-Rangel, Rogelio de J. ; Rojas, Olga C. ; González, Gloria M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-87c37d19bc049e83fb80875bbd46d9d7c8252a9a33ccd310717aea6a74781eab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Candida duobushaemulonii</topic><topic>Cutaneotrichosporon dermatis</topic><topic>Enzyme activity</topic><topic>Meyerozyma caribbica</topic><topic>Onychomycosis</topic><topic>Susceptibility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montoya, Alexandra M.</creatorcontrib><creatorcontrib>Luna-Rodríguez, Carolina E.</creatorcontrib><creatorcontrib>Bonifaz, Alexandro</creatorcontrib><creatorcontrib>Treviño-Rangel, Rogelio de J.</creatorcontrib><creatorcontrib>Rojas, Olga C.</creatorcontrib><creatorcontrib>González, Gloria M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal de mycologie médicale</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montoya, Alexandra M.</au><au>Luna-Rodríguez, Carolina E.</au><au>Bonifaz, Alexandro</au><au>Treviño-Rangel, Rogelio de J.</au><au>Rojas, Olga C.</au><au>González, Gloria M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physiological characterization and molecular identification of some rare yeast species causing onychomycosis</atitle><jtitle>Journal de mycologie médicale</jtitle><addtitle>J Mycol Med</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>31</volume><issue>2</issue><spage>101121</spage><epage>101121</epage><pages>101121-101121</pages><artnum>101121</artnum><issn>1156-5233</issn><eissn>1773-0449</eissn><abstract>Onychomycosis are infections with a variety of etiological agents. Although dermatophytes are responsible for most infections, yeasts are gaining importance as agents of these pathologies. The use of antifungals has increased the incidence of what had been considered rare or novel pathogens. We reidentify three rare yeasts from a culture collection of onychomycosis agents by matrix-assisted laser desorption/ionization time of flight/mass spectrometry (MALDI-TOF/MS) and sequencing the internal transcribed spacer (ITS) regions or the intergenic spacer (IGS) 1 region of ribosomal DNA (rDNA), and present their enzymatic and antifungal susceptibility profiles. We performed a phenotypical characterization and molecular identification of five yeast isolates. We tested the urease, gelatinase, DNase, phospholipase, protease, and esterase activities, as well as the hemolytic activity. We evaluated the antifungal susceptibility to amphotericin B, fluconazole, anidulafungin and caspofungin. Phenotypic methods could not identify the isolates. MALDI-TOF/MS was able to properly identify Candida duobushameulonii. The five isolates were successfully identified by sequence analysis as Candida duobushaemulonii, Meyerozyma caribbica and Cutaneotrichosporon dermatis. Candida duobushameulonii showed hemolytic, phospholipase, and protease activities. Meyerozyma caribbica was positive for gelatinase and protease activities. All antifungals exhibited minimum inhibitory concentrations (MICs) ≤2μg/mL against both species. The three isolates of Cutaneotrichosporon dermatis showed urease, DNase, and esterase activities, and resistance to echinocandins (MICs ≥8μg/mL), while amphotericin B and fluconazole exhibited low MICs against these isolates (0.50–2μg/mL). Sequencing of the ITS or IGS1 regions of rDNA remains the best method for identifying cryptic species over other commercially available systems. More reports are needed to define the enzymatic and antifungal profiles for these species. This is the first report of Meyerozyma caribbica and Cutaneotrichosporon dermatis as etiological agents of onychomycosis.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>33626414</pmid><doi>10.1016/j.mycmed.2021.101121</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1156-5233
ispartof Journal de mycologie médicale, 2021-06, Vol.31 (2), p.101121-101121, Article 101121
issn 1156-5233
1773-0449
language eng
recordid cdi_proquest_miscellaneous_2493454410
source Elsevier ScienceDirect Journals
subjects Candida duobushaemulonii
Cutaneotrichosporon dermatis
Enzyme activity
Meyerozyma caribbica
Onychomycosis
Susceptibility
title Physiological characterization and molecular identification of some rare yeast species causing onychomycosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T21%3A47%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physiological%20characterization%20and%20molecular%20identification%20of%20some%20rare%20yeast%20species%20causing%20onychomycosis&rft.jtitle=Journal%20de%20mycologie%20m%C3%A9dicale&rft.au=Montoya,%20Alexandra%20M.&rft.date=2021-06-01&rft.volume=31&rft.issue=2&rft.spage=101121&rft.epage=101121&rft.pages=101121-101121&rft.artnum=101121&rft.issn=1156-5233&rft.eissn=1773-0449&rft_id=info:doi/10.1016/j.mycmed.2021.101121&rft_dat=%3Cproquest_cross%3E2493454410%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2493454410&rft_id=info:pmid/33626414&rft_els_id=S1156523321000111&rfr_iscdi=true